References
- World Health Organization, Adherence to long-term therapies: evidence for action (I.). Geneva: World Health Organization; https://iris.who.int/handle/10665/42682; last access date July 22, 2025.
- S. T. Simon, V. Kini, A. E. Levy and P. M. Ho, Medication adherence in cardiovascular medicine, BMJ 374 (2021) Article ID n1493; https://doi.org/10.1136/bmj.n1493
- V. Giordano and L. Cardillo, The impact of ‘the medication non-adherence’ in patients with cardiovascular disease: causes, outcomes, and interventions. Review of the literature, Eur. Heart J. Suppl. 23 (2021) Article ID 290 (1 page); https://doi.org/10.1093/eurheartj/suab143.002
- Cardiovascular diseases (CVDs), World Health Organization, Fact Sheet, Cardiovascular diseases; https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds); last access date July 14, 2025.
- Q. Hou, Y. Zhao and Y. Wu, Medication adherence trajectories and clinical outcomes in patients with cardiovascular disease: A systematic review and meta-analysis, J. Glob. Health 15 (2025) Article ID 04145 (12 pages); https://doi.org/10.7189/jogh.15.04145
- G. M. C. Rosano, P. Seferovic, G. Savarese, I. Spoletini, Y. Lopatin, F. Gustafsson, A. Bayes-Genis, T. Jaarsma, M. Abdelhamid, A. G. Miqueo, M. Piepoli, C. G. Tocchetti, A. D. Ristić, E. Jankowska, B. Moura, L. Hill, G. Filippatos, M. Metra, D. Milcic, T. Thum, O. Chioncel, T. Ben Gal, L. H. Lund, D. Farmakis, W. Mullens, S. Adamopoulos, M. Bohm, A. Norhammar, A. Bollmann, A. Banerjee, A. P. Maggioni, A. Voors, A. Cohen Solal and A. J. S. Coats, Impact analysis of heart failure across European countries: An ESC-HFA position paper, ESC Heart Fail. 9(5) (2022) 2767–2778; https://doi.org/10.1002/ehf2.14076
- E. Zavaleta-Monestel, S. Arguedas-Chacón, A. Quirós-Romero, J. M. Chaverri-Fernández, B. Serrano-Arias, J. P. Díaz-Madriz, J. García-Montero and M. O. Speranza-Sanchez, Optimizing heart failure management: A review of the clinical pharmacist integration to the multidisciplinary health care team, Int. J. Heart Fail. 6(1) (2024) 1–10; https://doi.org/10.36628/ijhf.2023.0022
- A. B. Tang, S. C. Lewsey, C. W. Yancy, P. A. Heidenreich, S. J. Greene, L. A. Allen, M. Jessup, M. Bolles, C. Rutan, N. Navar, K. Thomas and G. C. Fonarow, Get with the Guidelines-Heart Failure: Twenty years in review, lessons learned, and the road ahead, Circulation: Heart Fail. 18(10) (2025) e012936 (11 pages); https://doi.org/10.1161/circheartfailure.125.012936
- T. A. McDonagh, M. Metra, M. Adamo, R. S. Gardner, A. Baumbach, M. Böhm, H. Burri, J. Butler, J. Čelutkienė, O. Chioncel, J. G. F. Cleland, A. J. S. Coats, M. G. Crespo-Leiro, D. Farmakis, M. Gi-lard, S. Heymans, A. W. Hoes, T. Jaarsma, E. A. Jankowska, M. Lainscak, C. S. P. Lam, A. R. Lyon, J. J. V. McMurray, A. Mebazaa, R. Mindham, C. Muneretto, M. F. Piepoli, S. Price, G. M. C. Rosano, F. Ruschitzka and A. K. Skibelund, 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC, Eur. Heart J. 42(36) (2021) 3599–3726; https://doi.org/10.1093/eurheartj/ehab368
- P. A. Heidenreich, B. Bozkurt, D. Aguilar, L. A. Allen, J. J. Byun, M. M. Colvin, A. Deswal, M. H. Drazner, S. M. Dunlay, L. R. Evers, J. C. Fang, S. E. Fedson, G. C. Fonarow, S. S. Hayek, A. F. Hernandez, P. Khazanie, M. M. Kittleson, C. S. Lee, M. S. Link, C. A. Milano, L. C. Nnacheta, A. T. Sandhu, L. W. Stevenson, O. Vardeny, A. R. Vest and C. W. Yancy, 2022 AHA/ACC/HFSA Guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Circulation 145(18) (2022) e895–e1032; https://doi.org/10.1161/CIR.0000000000001063
- R. Oosterom-Calo, A. J. van Ballegooijen, C. B. Terwee, S. J. te Velde, I. A. Brouwer, T. Jaarsma and J. Brug, Determinants of adherence to heart failure medication: A systematic literature review, Heart Fail. Rev. 18 (2013) 409–427; https://doi.org/10.1007/s10741-012-9321-3
- A. A. Fitzgerald, J. D. Powers, P. M. Ho, T. M. Maddox, P. N. Peterson, L. A. Allen, F. A. Masoudi, D. J. Magid and E. P. Havranek, Impact of medication nonadherence on hospitalizations and mortality in heart failure, J. Card. Fail. 17(8) (2011) 664–669; https://doi.org/10.1016/j.card-fail.2011.04.011
- D. Shah, K. Simms, D. J. Barksdale and J.-R. Wu, Improving medication adherence of patients with chronic heart failure: Challenges and solutions, RRCC 6 (2015) 87–95; https://doi.org/10.2147/RRCC.S50658
- F. J. Hafkamp, R. A. Tio, L. C. Otterspoor, T. de Greef, G. J. van Steenbergen, A. R. T. van de Ven, G. Smits, H. Post and D. van Veghel, Optimal effectiveness of heart failure management – an umbrella review of meta-analyses examining the effectiveness of interventions to reduce (re) hospitalizations in heart failure, Heart Fail. Rev. 27(5) (2022) 1683–1748; https://doi.org/10.1007/s10741-021-10212-8
- T. M. Ruppar, P. S. Cooper, D. R. Mehr, J. M. Delgado and J. M. Dunbar-Jacob, Medication adherence interventions improve heart failure mortality and readmission rates: Systematic review and meta-analysis of controlled trials, J. Am. Heart Assoc. 5(6) (2016) e002606 (18 pages); https://doi.org/10.1161/JAHA.115.002606
- A. H. Y. Chan, R. Horne, M. Hankins and C. Chisari, The Medication Adherence Report Scale: A measurement tool for eliciting patients’ reports of nonadherence, Br. J. Clin. Pharmacol. 86(7) (2020) 1281–1288; https://doi.org/10.1111/bcp.14193
- J. W. Cheng, Current perspectives on the role of the pharmacist in heart failure management, IPRP 7 (2018) 1–11; https://doi.org/10.2147/IPRP.S137882
- S. L. Anderson and J. C. Marrs, A Review of the role of the pharmacist in heart failure transition of care, Adv. Ther. 35(3) (2018) 311–323; https://doi.org/10.1007/s12325-018-0671-7
- Zakon o zdravstvenoj zaštiti, Narodne Novine, Zakon o zdravstvenoj zaštiti; https://narodnenovine.nn.hr/clanci/sluzbeni/2008_12_150_4097.html; last access date July 19, 2025.
- Zakon o zaštiti prava pacijenata, Narodne Novine, Zakon o zaštiti prava pacijenata; https://narodne-novine.nn.hr/clanci/sluzbeni/2004_12_169_2953.html; last access date July 19, 2025.
- J. L. Cohen, D. M. Mann, J. P. Wisnivesky, R. Horne, H. Leventhal, T. J. Musumeci-Szabó and E. A. Halm, Assessing the validity of self-reported medication adherence among inner-city asthmatic adults: The Medication Adherence Report Scale for asthma, annals of allergy, Asthma Immunol. 103(4) (2009) 325–331; https://doi.org/10.1016/S1081-1206(10)60532-7
- P. C. Baumgartner, R. B. Haynes, K. E. Hersberger and I. Arnet, A systematic review of medication adherence thresholds dependent of clinical outcomes, Front. Pharmacol. 9 (2018) Article ID 1290 (10 pages); https://doi.org/10.3389/fphar.2018.01290
- M. L. McHugh, Interrater reliability: The kappa statistic, Biochem. Med. (Zagreb) 22 (2012) 276–282; https://pmc.ncbi.nlm.nih.gov/articles/PMC3900052/
- K. S. Taber, The use of Cronbach’s alpha when developing and reporting research instruments in science education, Res. Sci. Educ. 48 (2018) 1273–1296; https://doi.org/10.1007/s11165-016-9602-2
- C. G. Forero, Cronbach’s Alpha, in Encyclopedia of Quality of Life and Well-Being Research (Ed. A. C. Michalos) Springer, Dordrecht 2014, pp. 1357–1359.
- M. Tavakol and R. Dennick, Making sense of Cronbach’s alpha, Int. J. Med. Educ. 2 (2011) 53–55; https://doi.org/10.5116/ijme.4dfb.8dfd
- Anatomical Therapeutic Chemical Classification, WHO Collaborating Centre for Drug Statistics Methodology, Anatomical Therapeutic Chemical classification and Defined Daily Dose system; https://atcddd.fhi.no/atc_ddd_index; last access date July 17, 2025.
- M. Alfaqeeh, R. Abdullah, N. Zakiyah, A. A. Suwantika, M. J. Postma, F. Rahmawati, A. W. Widayanti and B. Ibrahim, Medication adherence and contributing factors in patients with heart failure within the Middle East: A systematic review, Glob. Heart 20(1) (2025) Article ID 47 (19 pages); https://doi.org/10.5334/gh.1431
- M. Jarrah, Y. Khader, O. Alkouri, A. Al-Bashaireh, F. Alhalaiqa, A. Al Marzouqi, O. A. Qaladi, A. Alharbi, Y. M. Alshahrani, A. S. Alqarni and A. Oweis, Medication adherence and its influencing factors among patients with heart failure: A cross-sectional study, Medicina 59(5) (2023) Article ID 960 (11 pages); https://doi.org/10.3390/medicina59050960
- A. S. Jarab, W. A. Al-Qerem, H. W. Hamam, K. H. Alzoubi, S. R. Abu Heshmeh, T. L. Mukattash and E. Alefishat, Medication adherence and its associated factors among outpatients with heart failure, Patient Prefer Adher. 17 (2023) 1209–1220; https://doi.org/10.2147/PPA.S410371
- M. Huber, A. K. Busch, I. Stalder-Ochsner, A. J. Flammer and G. Schmid-Mohler, Medication adherence in adults after hospitalization for heart failure: A cross-sectional study, Int. J. Cardiol. Cardiovasc. Risk Prev. 20 (2023) Article ID 200234 (7 pages); https://doi.org/10.1016/j.ijcrp.2023.200234
- G. Y. Tarekegn, F. N. Dagnew, T. A. Moges, Z. A. Asmare, S. S. Tsega, D. G. Damtie, S. S. Anberbr, M. F. Semman and B. E. Bitew, Medication non-adherence and its predictors among chronic heart failure patients in Northwest Amhara region, Sci. Rep. 15(1) (2025) Article ID 19968 (13 pages); https://doi.org/10.1038/s41598-025-03748-4
- A. J. Nelson, N. J. Pagidipati and H. B. Bosworth, Improving medication adherence in cardiovascular disease, Nat. Rev. Cardiol. 21(6) (2024) 417–429; https://doi.org/10.1038/s41569-023-00972-1
- U. Religioni, R. Barrios-Rodríguez, P. Requena, M. Borowska and J. Ostrowski, Enhancing therapy adherence: Impact on clinical outcomes, healthcare costs, and patient quality of life, Medicina 61(1) (2025) Article ID 153 (12 pages); https://doi.org/10.3390/medicina61010153
- M. A. Parikh, S. Ramachandran, I. Nsiah, P. J. Campbell, M. Castora-Binkley, T. Karmakar, H. Black and J. P. Bentley, Estimating optimal thresholds for adherence to RASA medications among older adults with hypertension, JMCP 31(1) (2025) 25–32; https://doi.org/10.18553/jmcp.2025.31.1.25
- S. C. E. Chapman and A. H. Y. Chan, Medication nonadherence – definition, measurement, prevalence, and causes: Reflecting on the past 20 years and looking forwards, Front. Pharmacol. 16 (2025) Article ID 1465059 (10 pages); https://doi.org/10.3389/fphar.2025.1465059
- H. Bjørnstad, C. Frigaard, P. Gulbrandsen, J. Gerwing, H. Schirmer and J. Menichetti, Contextual factors affecting adherence revealed by old patients with heart failure in hospital and primary care interactions: A descriptive study, Patient Prefer Adher. 19 (2025) 1075–1087; https://doi.org/10.2147/PPA.S505297
- I. Bužančić, M. Balen, D. Arbanas, S. Falamić, K. Fehir Šola, A. Galić Skoko, M. Momčilović, A. Orbanić, A. Tatarević and M. Ortner Hadžiabdić, Development and validation of a tool to explore attitudes towards medication adherence using a novel self-reported questionnaire (ADHERE-7), Pharmacy 12(4) (2024) Article ID 113 (15 pages); https://doi.org/10.3390/pharmacy12040113
- K. Quaschning, M. Koerner and M. A. Wirtz, Analyzing the effects of barriers to and facilitators of medication adherence among patients with cardiometabolic diseases: A structural equation modeling approach, BMC Health Services Res. 22 (2022) 588 (14 pages); https://doi.org/10.1186/s12913-022-07987-3
- H. C. Oliveira, D. Hayashi, S. D. L. Carvalho, R. de C. L. de Barros, M. L. dos S. Neves, C. R. S. Andrechuk, N. M. C. Alexandre, P. A. B. Ribeiro and R. C. M. Rodrigues, Quality of measurement properties of medication adherence instruments in cardiovascular diseases and type 2 diabetes mellitus: a systematic review and meta-analysis, System. Rev. 12(1) (2023) Article ID 222 (24 pages); https://doi.org/10.1186/s13643-023-02340-z
- G. Campbell, C. Doherty, A. D’Silva, G. Carr-White, J. Webb and T. F. Ismail, Implementation and evaluation of specialist heart failure pharmacist prescribing clinics, Int. J. Clin. Pharm. 47(1) (2025) 8–14; https://doi.org/10.1007/s11096-024-01808-9
- D. Attar, J. Lekura, J. S. Kalus, W. Al-Darzi, C. T. Williams and G. F. Grafton, Impact of a pharmacist-led heart failure clinic on guideline-directed medical therapy, J. Card. Fail. 26(10) (2020) Article ID S129 (1 page); https://doi.org/10.1016/j.cardfail.2020.09.371
- P. Gupta, A. A. Voors, P. Patel, D. Lane, S. D. Anker, J. G. F. Cleland, K. Dickstein, G. Filippatos, C. C. Lang, D. J. van Veldhuisen, M. Metra, F. Zannad, N. J. Samani, D. J. L. Jones, I. B. Squire and L. L. Ng, Non-adherence to heart failure medications predicts clinical outcomes: Assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study), Eur. J. Heart Fail. 23(7) (2021) 1182–1190; https://doi.org/10.1002/ejhf.2160
- L. Jelínek, J. Václavík, Z. Ramík, L. Pavlů, K. Benešová, J. Jarkovský, M. Lazárová, H. Janečková, J. Spurná and M. Táborský, directly measured adherence to treatment in chronic heart failure: LEVEL-CHF Registry, Am. J. Med. Sci. 361(4) (2021) 491–498; https://doi.org/10.1016/j.amjms.2020.12.004
- A. M. Andrews and C. L. Russell, Impact of a SystemCHANGETM Intervention on medication adherence in older adults with heart failure: A feasibility study, J. Gerontol. Nurs. 45(4) (2019) 15–19; https://doi.org/10.3928/00989134-20190212-01
- J.-R. Wu, D. K. Moser, M. J. De Jong, M. K. Rayens, M. L. Chung, B. Riegel and T. A. Lennie, Defining an evidence-based cutpoint for medication adherence in heart failure, Am. Heart J. 157(2) (2009) 285–291; https://doi.org/10.1016/j.ahj.2008.10.001
- T. Cornelius, C. I. Voils, J. L. Birk, E. K. Romero, D. E. Edmondson and I. M. Kronish, Identifying targets for cardiovascular medication adherence interventions through latent class analysis, Health Psychol. 37(11) (2018) 1006–1014; https://doi.org/10.1037/hea0000661
- A. Kukulska and E. Garwacka-Czachor, Assessment of adherence to treatment recommendations among patients with heart failure: A cross-sectional study, BMC Cardiovasc. Disord. 24(1) (2024) Article ID 337 (10 pages); https://doi.org/10.1186/s12872-024-04001-y
- M. Minamisawa, B. Claggett, K. Suzuki, S. M. Hegde, A. M. Shah, A. S. Desai, E. F. Lewis, S. J. Shah, N. K. Sweitzer, J. C. Fang, I. S. Anand, E. O’Meara, J.-L. Rouleau, B. Pitt, M. A. Pfeffer, S. D. Solomon and O. Vardeny, Association of hyper-polypharmacy with clinical outcomes in heart failure with preserved ejection fraction, Circulation: Heart Failure 14(11) (2021) e008293 (27 pages); https://doi.org/10.1161/CIRCHEARTFAILURE.120.008293
- S. Scalvini, P. Bernocchi, S. Villa, A. M. Paganoni, M. T. La Rovere and M. Frigerio, Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: A population-based retrospective study on 100785 patients, Int. J. Cardiol. 330 (2021) 106–111; https://doi.org/10.1016/j.ijcard.2021.02.016
- J. Beezer, M. Al Hatrushi, A. Husband, A. Kurdi and P. Forsyth, Polypharmacy definition and prevalence in heart failure: A systematic review, Heart Fail. Rev. 27(2) (2022) 465–492; https://doi.org/10.1007/s10741-021-10135-4
- M. I.-M. Danjuma, A. A. Sukik, A. T. Aboughalia, M. Bidmos, Y. Ali, R. Chamseddine, A. Elzouki and O. Adegboye, In patients with chronic heart failure which polypharmacy pheno-groups are associated with adverse health outcomes? (Polypharmacy pheno-groups and heart failure outcomes), Curr. Problems Cardiol. 49(5) (2024) Article ID 102194 (12 pages); https://doi.org/10.1016/j.cpcardiol.2023.102194
- S. M. Dunlay, V. L. Roger, J. M. Killian, S. A. Weston, P. J. Schulte, A. V. Subramaniam, S. B. Blecker and M. M. Redfield, Advanced heart failure epidemiology and outcomes, JACC: Heart Fail. 9(10) (2021) 722–732; https://doi.org/10.1016/j.jchf.2021.05.009
- A. A. Morris, P. Khazanie, M. H. Drazner, N. M. Albert, K. Breathett, L. B. Cooper, H. J. Eisen, P. O’Gara and S. D. Russell, on behalf of the American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; and Council on Hypertension, Guidance for timely and appropriate referral of patients with advanced heart failure: A scientific statement from the American Heart Association, Circulation 144(15) (2021) e238–e250; https://doi.org/10.1161/CIR.0000000000001016
- O. Chioncel, J. Čelutkienė, J. Bělohlávek, G. Kamzola, M. Lainscak, B. Merkely, D. Miličić, J. Nessler, A. Ristić, L. Sawiełajc, I. Uchmanowicz, T. Uuetoa, E. Turgonyi, Y. Yotov and P. Ponikowski, Heart failure care in the Central and Eastern Europe and Baltic region: Status, barriers, and routes to improvement, ESC Heart Fail. 11 (2024) 1861–1874; https://doi.org/10.1002/ehf2.14687
- V. Kralj and I. Grahovac, Epidemiology of cardiovascular diseases in Croatia, Cardiologia Croatica 17(9–10) (2022) 333–333; https://doi.org/10.15836/ccar2022.333